Medical Strategy is where scientific and clinical knowledge meets strategic application. This 2-year Fellowship provides a unique opportunity to support the development and execution of Worldwide and U.S. Oncology Medical Strategy and other medical activities in the emerging field of Immuno-Oncology (I-O). During the first year in Worldwide Medical Strategy, the Fellow will focus on developing the global strategy for new I-O indications in a wide array of tumor types through collaborative efforts with BMS regional offices around the world. During the second year in U.S. Medical, the Fellow will be on the Franchise Medical team where the focus will be on developing and executing the U.S. strategy for the successful launch and continued support of I-O indications. The Fellow will gain exposure and develop leadership skills by supporting and leading medical initiatives in collaboration with the Worldwide and U.S. cross functional matrix teams (i.e., Field Medical, Medical Publications, Health Economics & Outcomes Research, Clinical Research, Clinical Operations, Regulatory, Marketing, Competitive Intelligence, and Access).
GLOBAL MEDICAL: WORLDWIDE MEDICAL STRATEGY
Gain experience in the development of a strategically-aligned Global Medical Plan based upon unmet medical need by collaborating with a cross functional, multi-regional (i.e., U.S., E.U., Asia-Pacific) Worldwide Medical matrix team
Engage with external Thought Leaders in an effort to exchange and gather scientific and clinical knowledge through investigator meetings, advisory boards, thought leader engagements, publication planning, and congresses
Lead the execution of medical deliverables that are closely aligned with the strategic Global Medical Plan, including National and International Congress planning for activities such as advisory boards, symposia, and thought leader engagements
Collaborate with BMS country-specific medical colleagues to collect field insights that will support strategic planning and tactical execution
Actively participate in the review and approval process of Investigator Sponsored Research proposals that are aligned with the data generation plan detailed in the Global Medical Plan
U.S. MEDICAL: U.S. FRANCHISE MEDICAL
Facilitate development of US Immuno-Oncology (I-O) portfolio franchise execution strategies and tactics through Medical and Marketing cross-functional team collaboration
Actively participate in development and execution of Immuno-Oncology brand franchise tactics and optimization of US Franchise Medical capabilities including launch readiness plans, medical conference activities, advisory board planning and execution, Thought Leader identification and engagements, internal medical training and external I-O educational resource development
Engage with U.S. Thought Leaders in scientific exchange via advisory boards, development of educational materials, and congresses
Please consider attending Fellowship Information and Network Day here at Rutgers Ernest Mario School of Pharmacy on November 22nd from 3:30 PM – 8:00 PM so we can visit with you about your interests. For additional information please visit our website: http://pharmafellows.rutgers.edu/applicants/fid.php.
We do not pre-schedule interviews for Midyear, so please do not request an interview via this website. Your emails will not be reviewed.
We will be scheduling interviews starting at 10 AM on December 7th. Prior to scheduling an interview you will need to view the Fellowship information video
Rutgers, The State University of New Jersey, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, gender identity or expression, disability, age, or any other category covered by law in its admission, programs, activities, or employment matters. The following people have been designated to handle inquiries regarding the nondiscrimination policies: Judy Ryan, Universitywide Title IX Coordinator, Office of Enterprise Risk Management, Ethics, and Compliance (732-235-5304, email@example.com); and Lisa Grosskreutz, Director, Office of Employment Equity, University Human Resources (848-932-3980, firstname.lastname@example.org). For further information on the notice of nondiscrimination, you may contact the U.S. Department of Education, Office for Civil Rights, at 646-428-3900 or OCR.NewYork@ed.gov.
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.